Del Monte Pacific FY2026 slides: revenue up 14%, margins expand

Del Monte Pacific posted strong FY2026 results, with revenue up 13.5% to US$896.1 million, EBITDA up 26.2% to US$181.1 million, and net profit rising to US$48.4 million, while gross margin expanded to 33.2%. However, negative equity of US$587 million and US$977 million of net debt continue to block dividends and drive restructuring efforts, despite improved leverage to 5.4x net debt/EBITDA. Management expects profitability in FY2027 and submitted a Financial Recovery Plan, while shares were down 1.2% at $0.082 on balance-sheet concerns.

Analysis

The key second-order signal is that the operating business is now likely worth materially more on a sum-of-parts basis than the parent’s quoted equity suggests, but the catalyst path is still balance-sheet-led, not earnings-led. Stronger pricing and mix in Asia can keep EBITDA compounding, yet the equity remains effectively an option on a successful creditor reset; until that process gains legal clarity, operating upside will mostly accrue to debt holders and only indirectly to equity.

That creates a bifurcation trade: the core consumer franchise in the Philippines and North Asia is defensively improving just as the parent structure remains fragile. If management can sustain mid-teens international growth and low-30s gross margins for several quarters, the market may start to discount a refinancing outcome rather than a liquidation scenario, but that re-rating likely needs proof of cash conversion, not just accounting profitability. The current weak cash flow versus EBITDA is the main watch item because inventory build and agricultural capex can quickly erode apparent deleveraging progress.

The main catalyst window is 3-9 months: creditor negotiations, recovery plan milestones, and whether management can demonstrate that supply-chain inflation and climate volatility are contained without sacrificing volume. The contrarian angle is that the negative-equity headline may be over-penalizing the ongoing Asia franchise, but the stock is also not cheap enough to ignore restructuring risk because any delay in the debt process can swamp operational improvement. In other words, this is less a normal turnaround than a capital-structure arbitration with an operating growth overlay.

Key Decisions for Investors

• Long DMPL only as a restructuring option: initiate a small starter position on pullbacks with a 3-6 month horizon; target a re-rating if creditor discussions progress, but size at <1% NAV because downside is dominated by capital-structure failure rather than earnings volatility.
• Do not chase the equity on operating beat alone; wait for one quarter of improved operating cash flow conversion before adding. The best risk/reward entry is after evidence that inventory normalization is reducing cash drag, not when EBITDA headlines are strongest.
• For credit investors, look at the debt stack as the cleaner expression of the turnaround. Favor senior secured exposure over equity because the business is generating enough operating profit to support a restructuring, but not enough free cash flow to make equity the highest-conviction claim.
• Pair trade idea: long a basket of Asian consumer staples with domestic pricing power vs short capital-structure stressed consumer names. The thesis is that brands with balance-sheet flexibility will rerate faster than similarly strong operators trapped in restructuring.
• Set a catalyst watch for the next 1-2 disclosure cycles on creditor talks and cash flow. If no concrete progress emerges, fade any equity strength because time is the enemy here; if a formal restructuring framework is announced, expect a sharp but likely tradable squeeze in the equity over days, not months.